1 - 66 of about 66
English: Nagato T, Komatsuda H, Hayashi R, Takahara M, Ujiie N, Kosaka A, Ohkuri T, Oikawa K, Sato R, Wakisaka R, Kono M, Yamaki H, Ohara K, Kumai T, Kishibe K, Katada A, Hayashi T, Kobayashi H., Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma. , Cancer Sci. , 2024 , (IF:5.7)
English: Murai A, Kubo T, Ohkuri T, Yanagawa J, Yajima Y, Kosaka A, Li D, Nagato T, Murata K, Kanaseki T, Tsukahara T, Nagasaki T, Hirohashi Y, Kobayashi H, Torigoe T., NF9 peptide specific cytotoxic T lymphocyte clone cross react to Y453F mutation of SARS-CoV-2 virus spike protein. , Immunol Med. , 2024 , (IF:4.4)
English: Yajima Y, Kosaka A, Ohkuri T, Hirohashi Y, Li D, Nagasaki T, Nagato T, Torigoe T, Kobayashi H., SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity. , Heliyon , vol.9 (9) (p.e20192 - ) , 2023 , (IF:4)
English: Yamaki H, Kono M, Wakisaka R, Komatsuda H, Kumai T, Hayashi R, Sato R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Hayashi T, Kobayashi H, Katada A., Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer. , Cancer Immunol Immunother. , vol.72 (8) (p.2799 - 2812) , 2023 , (IF:5.8)
English: Nagato T, Komatsuda H, Hayashi R, Takahara M, Kishibe K, Yasuda S, Yajima Y, Kosaka A, Ohkuri T, Oikawa K, Harabuchi S, Kono M, Yamaki H, Wakisaka R, Hirata- Nozaki Y, Ohara K, Kumai T, Katada A, Hayashi T, Harabuchi Y, Kobayashi H., Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy. , Cancer Immunol Immunother. , vol.27 (2) (p.2087 - 2098) , 2023 , (IF:6.630)
English: Kosaka A, Yajima Y, Yasuda S, Komatsuda H, Nagato T, Oikawa K, Kobayashi H, Ohkuri T. , Celecoxib promotes the efficacy of STING-targeted therapy by increasing antitumor CD8+ T-cell functions via modulating glucose metabolism of CD11b+Ly6G+ cells. , Int J Cancer , vol.152 (8) (p.1685 - 1697) , 2023 , (IF:7.316)
English: Komatsuda H, Wakisaka R, Kono M, Kumai T, Hayashi R, Yamaki H, Sato R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Takahara M, Katada A, Kobayashi H. , MAPK inhibition augments the T-cell response against HOXB7-expressing tumor through HLA upregulation. , Cancer Sci. , vol.114 (2) (p.399 - 409) , 2023 , (IF:6.518)
English: Xiang H, Toyoshima Y, Shen W, Wang X, Okada N, Kii S, Sugiyama K, Nagato T, Kobayashi H, Ikeo K, Hashimoto S, Tanino M, Taketomi A, Kitamura H., IFN-α/β-mediated NK2R expression is related to the malignancy of colon cancer cells. , Cancer Sci. , vol.113 (8) (p.2513 - 2525) , 2022 , (IF:6.518)
English: Yajima Y, Kosaka A, Ishibashi K, Yasuda S, Komatsuda H, Nagato T, Oikawa K, Kitada M, Takekawa M, Kumai T, Ohara K, Ohkuri T, Kobayashi H., A tumor metastasis-associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity. , Cancer Sci. , vol.113 (8) (p.2526 - 2535) , 2022 , (IF:6.518)
English: Sakurai Y, Toriumi N, Sarashina T, Ishioka T, Nagata M, Kobayashi H, Azuma H., An infantile case of hereditary folate malabsorption with sudden development of pulmonary hemorrhage: a case report. , J Med Case Rep. , vol.16 (1) (p.268 - ) , 2022
English: Kubota A, Ishida Y, Hashiguchi J, Sato R, Wada T, Bandoh N, Sato K, Kobayashi H, Nishihara H, Harabuchi Y., A case of primary histiocytic sarcoma arising from a neck lymph node. , Ear Nose Throat J. , 2022 , (IF:1.697)
English: Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Katada A, Hayashi T, Kobayashi H, Harabuchi Y., Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. , Oncoimmunology , vol.11 (1) (p.2021619 - ) , 2022 , (IF:8.110)
English: Kono M, Kumai T, Hayashi R, Yamaki H, Komatsuda H, Wakisaka R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Katada A, Hayashi T, Celis E, Kobayashi H, Harabuchi Y, Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery , Cancer Immunol Immunother , vol.70 (12) (p.3421 - 3434) , 2021 , (IF:6.968)
English: Kosaka A, Ishibashi K, Nagato T, Kitamura H, Fujiwara Y, Yasuda S, Nagata M, Harabuchi S, Hayashi R, Yajima Y, Ohara K, Kumai T, Aoki N, Komohara Y, Oikawa K, Harabuchi Y, Kitada M, Kobayashi H, Ohkuri T. , CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes. , J Exp Med. , vol.218 (11) (p.e20200792 - ) , 2021 , (IF:14.307)
English: Kaneko S, Matsuda K, Mizuta Y, Shiratori S, Kishi K, Nakamura A, Yagisawa M, Ehira N, Uebayashi M, Kobayashi H., Severe spruelike enteropathy and collagenous colitis caused by olmesartan. , BMC Gastroenterol. , vol.21 (1) (p.350 - ) , 2021 , (IF:3.067)
English: Kosaka A, Yajima Y, Hatayama M, Ikuta K, Sasaki T, Hirai N, Yasuda S, Nagata M, Hayashi R, Harabuchi S, Ohara K, Ohara M, Kumai T, Ishibashi K, Hirata-Nozaki Y, Nagato T, Oikawa K, Harabuchi Y, Celis E, Okumura T, Ohsaki Y, Kobayashi H, Ohkuri T, A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy. , Cancer Sci , vol.112 (7) (p.2705 - 2713) , 2021 , (IF:6.716)
English: Okazaki S, Sasaki T, Yasuda S, Abe M, Yoshida N, Yoshida R, Ishibashi K, Minami Y, Okumura S, Chiba S, Takei H, Hayashi R, Nagato T, Kobayashi H, Sugitani A, Ono Y, Mizukami Y, Kitada M, Ohsaki Y., The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer. , Oncol Lett. , vol.21 (5) (p.430 - ) , 2021 , (IF:2.967)
English: Nagata M, Kosaka A, Yajima Y, Yasuda S, Ohara M, Ohara K, Harabuchi S, Hayashi R, Funakoshi H, Ueda J, Kumai T, Nagato T, Oikawa K, Harabuchi Y, Esteban C, Ohkuri T, Kobayashi H., A critical role of STING-triggered tumor- migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment. , Cancer Immunol Immunother. , 2021 , (IF:6.968)
English: Hayashi R, Nagato T, Kumai T, Ohara K, Ohara M, Ohkuri T, Hirata-Nozaki Y, Harabuchi S, Kosaka A, Nagata M, Yajima Y, Yasuda S, Oikawa K, Kono M, Kishibe K, Takahara M, Katada A, Hayashi T, Celis E, Harabuchi Y, Kobayashi H., Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma. , Oncoimmunology. , vol.10 (1) (p.1856545 - ) , 2021 , (IF:8.110)
English: Yoshida Y, Nagamori T, Ishibazawa E, Kobayashi H, Kure T, Sakai H, Takahashi D, Fujihara M, Azuma H., Contribution of long-chain fatty acid to induction of myeloid-derived suppressor cell (MDSC)-like cells - induction of MDSC by lipid vesicles (liposome). , Immunopharmacol Immunotoxicol. , vol.42 (6) (p.614 - 624) , 2020 , (IF:2.730)
English: Ohara M, Ohara K, Kumai T, Ohkuri T, Nagato T, Hirata-Nozaki Y, Kosaka A, Nagata M, Hayashi R, Harabuchi S, Yajima Y, Oikawa K, Harabuchi Y, Sumi Y, Furukawa H, Kobayashi H., Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer. , Cancer Immunol Immunother. , vol.69 (6) (p.989 - 999) , 2020 , (IF:6.968)
English: Harabuchi S, Kosaka A, Yajima Y, Nagata M, Hayashi R, Kumai T, Ohara K, Nagato T, Oikawa K, Ohara M, Harabuchi Y, Ohkuri T, Kobayashi H., Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma. , Biochem Biophys Res Commun. , vol.522 (2) (p.408 - 414) , 2020 , (IF:3.575)
English: Hirata-Nozaki Y, Ohkuri T, Ohara K, Kumai T, Nagata M, Harabuchi S, Kosaka A, Nagato T, Ishibashi K, Oikawa K, Aoki N, Ohara M, Harabuchi Y, Uno Y, Takei H, Celis E, Kobayashi H., PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma. , J Transl Med. , vol.17 (1) (p.1430 - ) , 2019 , (IF:5.531)
English: Nagato T, Ueda S, Takahara M, Kishibe K, Komabayashi Y, Kumai T, Ohara K, Hirata-Nozaki Y, Harabuchi S, Hayashi R, Ohkuri T, Bernasconi M, Nadal D, Kobayashi H, Harabuchi Y., Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma. , Lab Invest. , vol.99 (5) (p.612 - 624) , 2019 , (IF:5.662)
English: Kenzo Ohara, Takayuki Ohkuri, Takumi Kumai, Toshihiro Nagato, Yui Hirata-Nozaki, Kei Ishibashi, Akemi Kosaka, Marino Nagata, Shohei Harabuchi, Mizuho Ohara, Kensuke Oikawa, Naoko Aoki, Yasuaki Harabuchi, Esteban Celis, and Hiroya Kobayashi. , Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma , Oncoimmunology , vol.7 (9) (p.e1466771. - ) , 2018 , (IF:7.719)
English: Sultan H, Kumai T, Fesenkova VI, Fan AE, Wu J, Cho HI, Kobayashi H, Harabuchi Y, Celis E., Sustained persistence of IL2 signaling enhances the antitumor effect of peptide vaccines through T-cell expansion and preventing PD-1 inhibition. , Cancer Immunol Res. , vol.6 (5) (p.617 - 627) , 2018 , (IF:9.188)
English: Ohkuri T, Kosaka A, Nagato T, Kobayashi H., Effects of STING stimulation on macrophages: STING agonists polarize into "classically" or "alternatively" activated macrophages? , Hum Vaccin Immunother , vol.14 (2) (p.285 - 287) , 2018 , (IF:2.157)
English: Uehara J, Ohkuri T, Kosaka A, Ishibashi K, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Ishida-Yamamoto A, Kobayashi H. , Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb. , Biochem Biophys Res Commun. , vol.490 (2) (p.521 - 527) , 2017 , (IF:2.466)
English: Kumai T, Kobayashi H, Harabuchi Y, Celis E., Peptide vaccines in cancer-old concept revisited. , Curr Opin Immunol. , vol.45 (p.1 - 7) , 2017 , (IF:8.384)
English: Azuma H, Yoshida Y, Takahashi H, Ishibazawa E, Kobayashi H, Sakai H, Takahashi D, Fujihara M., Liposomal microparticle injection can induce myeloid-derived suppressor cells (MDSC)-like cells in vivo. , Immunopharmacol Immunotoxicol , vol.5 (p.1 - 8) , 2017 , (IF:1.617)
English: Kumai T, Lee S, Cho HI, Sultan H, Kobayashi H, Harabuchi Y, Celis E., Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses. , Cancer Immunol Res. , vol.5 (1) (p.72 - 83) , 2017 , (IF:8.284)
English: Ohkuri T, Kosaka A, Ishibashi K, Kumai T, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H., Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site. , Cancer Immunol Immunother. , vol.66 (6) (p.705 - 716) , 2017 , (IF:4.711)
English: Nagato T, Ohkuri T, Ohara K, Hirata Y, Kishibe K, Komabayashi Y, Ueda S, Takahara M, Kumai T, Ishibashi K, Kosaka A, Aoki N, Oikawa K, Uno Y, Akiyama N, Sado M, Takei H, Celis E, Harabuchi Y, Kobayashi H., Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy. , Cancer Immunol Immunother. , vol.66 (7) (p.877 - 890) , 2017 , (IF:4.711)
English: Oikawa K, Odero GL, Nafez S, Ge N, Zhang D, Kobayashi H, Sate K, Kimura S, Tateno M, Albensi BC., Visinin-Like Protein-3 Modulates the Interaction Between Cytochrome b (5) and NADH-Cytochrome b (5) Reductase in a Ca(2+)-Dependent Manner. , Cell Biochem Biophys. , vol.74 (4) (p.449 - 457) , 2016 , (IF:1.627)
English: Kumai T, Oikawa K, Aoki N, Kimura S, Harabuchi Y, Kobayashi H., Assessment of the change in cetuximab induced ADCC activity of NK cells by steroid. Kumai T, Oikawa K, Aoki N, Kimura S, Harabuchi Y, Kobayashi H. , Head & Neck , vol.38 (3) (p.410 - 416) , 2016 , (IF:3.006)
English: Ishibashi K, Kumai T, Ohkuri T, Kosaka A, Nagato T, Hirata Y, Ohara K, Oikawa K, Aoki N, Akiyama N, Sado M, Kitada M, Harabuchi Y, Celis E, Kobayashi H., Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy. , Oncoimmunology , vol.30 (5) (p.e1169356 - ) , 2016 , (IF:7.644)
English: Kumai T, Kobayashi H, Harabuchi Y., Novel targets for natural killer/T-cell lymphoma immunotherapy. , Immunotherapy , vol.8 (1) (p.45 - 55) , 2016 , (IF:2.070)
English: Shimouchi A, Yokota H, Ono S, Matsumoto C, Tamai T, Takumi H, Narayanan SP, Kimura S, Kobayashi H, Caldwell RB, Nagaoka T, Yoshida A., Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury. , Jpn J Ophthalmol. , vol.60 (1) (p.51 - 61) , 2016 , (IF:1.676)
English: Ohtake J, Kaneumi S, Tanino M, Kishikawa T, Terada S, Sumida K, Masuko K, Ohno Y, Kita T, Iwabuchi S, Shinohara T, Tanino Y, Takemura T, Tanaka S, Kobayashi H, Kitamura H., Neuropeptide signaling through neurokinin-1 and neurokinin-2 receptors augments antigen presentation by human dendritic cells. , J Allergy Clin Immunol. , vol.136 (6) (p.1690 - 1694) , 2015 , (IF:11.476)
English: Kumai T, Ohkuri T, Nagato T, Matsuda Y, Oikawa K, Aoki N, Kimura S, Celis E, Harabuchi Y, Kobayashi H., Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma. , Sci Rep. , vol.5 (5) (p.16280 - ) , 2015 , (IF:5.578)
English: Kumai T, Nagato T, Kobayashi H, Komabayashi Y, Ueda S, Kishibe K, Ohkuri T, Takahara M, Celis E, Harabuchi Y., CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma. , Cancer Immunol Immunother. , 2015 , (IF:3.943)
English: Kumai T, Matsuda Y, Ohkuri T, Oikawa K, Ishibashi K, Aoki N, Kimura S, Harabuchi Y, Celis E, Kobayashi H., c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma. , OncoImmunology , vol.4 (2) (p.e976077 - ) , 2015 , (IF:6.283)
English: Kumai, T., Ishibashi, K., Oikawa, K., Matsuda, Y., Aoki, N., Kimura, S., Hayashi, S., Kitada, M., Harabuchi, Y., Celis, E., Kobayashi, H., Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53. , Cancer Immunol Immunother. , vol.63 (5) (p.469 - 478) , 2014 , (IF:3.943)
English: Kumai T, Oikawa K, Aoki N, Kimura S, Harabuchi Y, Celis E, Kobayashi H., Tumor-derived TGF-ß and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor. , J Transl Med. , vol.12 (1) (p.265 - ) , 2014 , (IF:3.991)
English: Kumai T, Matsuda Y, Oikawa K, Aoki N, Kimura S, Harabuchi Y, Celis E,Kobayashi H, EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy. , Br J Cancer , vol.15 (109) (p.2155 - 2166) , 2013 , (IF:5.082)
English: Kobayashi H, Kumai T, Hayashi S, Matsuda Y, Aoki N, Sato K, Kimura S, Celis E., A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitope. , Cancer Immunol Immunother. , vol.61 (12) (p.2215 - 2225) , 2012 , (IF:3.701)
English: Hayashi S, Kumai T, Matsuda Y, Aoki N, Sato K, Kimura S, Kitada M, Tateno M, Celis E, Kobayashi H. , Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer , J Transl Med. , vol.9 (p.191 - ) , 2011 , (IF:3.47)
English: Kobayashi H, Azumi M, Hayashi S, Sato K, Aoki N, Kimura S, Kakizaki H, Nagato T, Harabuchi Y, Tateno M, Celis E, Characterization of human CD4 helper T cell responses against Aurora kinase A. , Cancer Immunol Immunother , vol.59 (7) (p.1029 - 1039) , 2010 , (IF:3.791)
English: Azumi M, Kobayashi H, Aoki N, Sato K, Kimura S, Kakizaki H, Tateno M. , Six-transmembrane epitherial antigen of prostate as an immunotherapeutic target for reanal cell and bladder cancers. , J Urol , vol.183 ((5)) (p.2036 - 2044) , 2010 , (IF:3.746)
English: Kobayashi H, Azumi M, Kimura Y, Sato K, Aoki N, Kimura S, Honma M, Iizuka H, Tateno M, Celis E. , Focal adhesion kinase as an immunotherapeutic target. , Cancer Immunol Immunother , vol.58 (p.931 - 940) , 2009 , (IF:3.701)
English: Aoki N, Kimura Y, Kimura S, Nagaro T, Azumi M, Kobayashi H, Sato K, Tateno M., Expression and functional role of MDL-1(CLEC5A) in mouse myeloid lineage cells. , J Leukoc Biol , vol.85 (p.508 - 517) , 2009 , (IF:4.992)
English: Kobayashi H, Nagato T, Takahara M, Sato K, Kimura S, Aoki N, Azumi M, Tateno M, Harabuchi Y, Celis E. , Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells. , Cancer Res , vol.68 (p.901 - 908) , 2008 , (IF:7.856)
English: Kobayashi H, Celis E. , Peptide epitope identification for tumor-reactive CD4 T cells. , Curr Opin Immunol , vol.20 (p.221 - 227) , 2008 , (IF:9.552)
English: Nomura Y, Abe Y, Ishida Y, Kobayashi H, Harabuchi Y. , Promiscuous peptides on the nontypeable haemophilus influenzae p6 outer membrane protein. , J Clin Immunol , vol.28 (p.361 - 369 ) , 2008 , (IF:3.077)
English: Nagato T,* Kobayashi H,* Yanai M, Sato K, Aoki N, Oikawa K, Kimura S, Abe Y, Celis E, Harabuchi Y, Tateno M. , Functional analysis of birch pollen allergen Bet v 1-specific regulatory T cells. , J Immunol , vol.178 (p.1189 - 1198) , 2007 , (IF:6.387)
English: Yanai M, Sato K, Aoki N, Takiyama Y, Oikawa K, Kobayashi H, Kimura S, Harabuchi Y, Tateno M. , The role of CCL22/macrophage-derived chemokine in allergic rhinitis. , Clin Immunol , vol.125 (p.291 - 298) , 2007
English: Kobayashi H, Nagato T, Sato K, Aoki N, Kimura S, Murakami M, Iizuka H, Azumi M, Kakizaki H, Tateno M, Celis E. , Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner. , Cancer Res , vol.67 (p.5498 - 5504) , 2007
English: Kobayashi H, Nagato T, Aoki N, Sato K, Kimura S, Tateno M, Celis E. , Defining MHC class II T helper epitopes for WT1 tumor antigen. , Cancer Immunol Immunother , vol.55 ((7)) (p.850 - 860) , 2006 , (IF:4.086)
English: shida Y, Abe Y, Yanai M, Kobayashi H, Harabuchi Y., Identification of human T cell epitopes and highly immunogenic analogue peptides on the non-typeable Hemophilus influenza p6 outer membrane protein. , Clin Immunol , vol.121 (p.90 - 99) , 2006 , (IF:3.217)
English: Kobayashi H, Nagato T, Sato K, Aoki N, Kimura S, Tanaka Y, Aizawa H,Tateno M, Celis E. , In vitro peptide immunization of target Tax protein human T-cell leukemia virus type-1-specific CD4+ helper T lymphocytes. , Clin Cancer Res , vol.12 (p.3814 - 3822) , 2006 , (IF:5.715)
English: Kobayashi H, Nagato T, Oikawa K, Sato K, Kimura S, Aoki N, Omiya R, Tateno M, Celis E. , Recognition of prostate and breast tumor cells by helper T lymphocytes specific for a prostate and breast tumor-associated antigen, helper T lymphocytes specific for a prostate tumor-associated antigen, TARP. , Clin Cancer Res , vol.11 (p.3869 - 3878) , 2005 , (IF:5.715)
English: Nagato T, Kobayashi H, Kishibe K, Takahara M, Ogino T, Ishii H, Oikawa K, Aoki N, Sato K, Kimura S, Shimizu N, Tateno M, Harabuchi Y., Expression of interleukin9 in nasal natural killer (NK)/T-cell lymphoma cell lines and patients: possible role as an autocrine growth factor. , Clin Cancer Res , vol.11 (p.8285 - 8257) , 2005 , (IF:5.715)
English: Ruiz, M., Kobayashi, H., Lasarte, J.J., Prieto, J., Borras-Cuesta, F., Celis, E., and Sarobe, P. , Identification and characterization of a T-helper peptide from carcinoembrionic antigen. , Clin. Cancer Res ((10)) (p.2860 - 2867) , 2004 , (IF:5.715)
English: Takiyama Y, Miyokawa N, Sugawara A, Kato S, Ito K, Sato K, Oikawa K, Kobayashi H, Kimura S, Tateno M., Decreased expression of retinoid X receptor isoforms in human thyroid carcinomas. , J Clin Endocrinol Metab , vol.89 (p.5851 - 5856) , 2004 , (IF:6.02)
English: Kobayashi H, Nagato T, Yanai M, Oikawa K, Sato K, Kimura S, Tateno M, Omiya R, Celis E., Recognition of adult T cell leukemia/lymphoma cells by CD4+ helper T lymphocytes specific for human T cell leukemia virus type I envelope protein. , Clin Cancer Res , vol.10 (p.7053 - 7062) , 2004 , (IF:5.715)
English: Oikawa K, Kimura S, Aoki N, Atsuta Y, Takiyama Y, Nagato T, Yanai M, Kobayashi H, Sato K, Sasajima T, Tateno M. , Neuronal calcium sensor protein visinin-like protein-3 interacts with microsomal cytochrome b5 in a Ca2+-dependent manner. , J Biol Cem , vol.279 (p.15142 - 15152) , 2004 , (IF:5.854)
Page: [<<PREV] [1] [NEXT>>]
Copyright (C) 2012~ Asahikawa Medical University, All Rights Reserved.